ZNF451 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.468000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.042200E-01
Normal-vs-Stage2
4.341000E-01
Normal-vs-Stage3
2.530600E-01
Normal-vs-Stage4
5.958800E-01
Stage1-vs-Stage2
7.228800E-01
Stage1-vs-Stage3
8.325700E-02
Stage1-vs-Stage4
4.195600E-01
Stage2-vs-Stage3
9.337900E-02
Stage2-vs-Stage4
2.150000E-01
Stage3-vs-Stage4
1.045780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.510000E-01
Normal-vs-AfricanAmerican
4.310800E-01
Normal-vs-Asian
3.710800E-01
Caucasian-vs-AfricanAmerican
8.290600E-01
Caucasian-vs-Asian
3.472200E-01
AfricanAmerican-vs-Asian
6.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.296000E-01
Normal-vs-Female
4.732800E-01
Male-vs-Female
3.810600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.732000E-01
Normal-vs-Age(41-60Yrs)
5.417600E-01
Normal-vs-Age(61-80Yrs)
4.093800E-01
Normal-vs-Age(81-100Yrs)
1.978170E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.049800E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.993430E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.086400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.839700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.014800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.037800E-01
Normal-vs-Daily Drinker
3.288400E-01
Normal-vs-Weekly Drinker
4.204200E-01
Normal-vs-Occasional Drinker
4.656600E-01
Normal-vs-Social Drinker
2.630200E-01
Non Drinker-vs-Daily Drinker
2.486400E-01
Non Drinker-vs-Weekly Drinker
8.661800E-01
Non Drinker-vs-Occasional Drinker
4.264000E-02
Non Drinker-vs-Social Drinker
3.824800E-01
Daily Drinker-vs-Weekly Drinker
2.140800E-01
Daily Drinker-vs-Occasional Drinker
8.961900E-03
Daily Drinker-vs-Social Drinker
1.213990E-01
Weekly Drinker-vs-Occasional Drinker
1.188620E-01
Weekly Drinker-vs-Social Drinker
5.364400E-01
Occasional Drinker-vs-Social Drinker
3.968800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.072980E-01
Normal-vs-Grade 2
1.108070E-02
Normal-vs-Grade 3
2.581700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.704800E-01
Grade 1-vs-Grade 3
9.261800E-01
Grade 1-vs-Grade 4
1.072980E-01
Grade 2-vs-Grade 3
9.272800E-01
Grade 2-vs-Grade 4
1.108070E-02
Grade 3-vs-Grade 4
2.581700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.940600E-01
Normal-vs-NonDiabetic
4.352600E-01
Diabetic-vs-NonDiabetic
4.279200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.556000E-01
Normal-vs-NoPancreatitis
4.337200E-01
Pancreatitis-vs-NoPancreatitis
3.262800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.834000E-02
Normal-vs-N1
4.411000E-01
N0-vs-N1
8.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.758400E-01
Normal-vs-TP53-NonMutant
5.656800E-01
TP53-Mutant-vs-TP53-NonMutant
2.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
